Electra Therapeutics vs Synthekine

Electra Therapeutics logo

Electra Therapeutics

A unique vision on mastering SIRP. A new way to change lives

25 employees · est. 2018

VS
Synthekine logo

Synthekine

Synthekine a biotechnology company focused on discovery and developing best in class cytokine therapeutics

62 employees · est. 2018 · Menlo Park, United States

Synthekine is the larger of the two.

Side-by-Side Comparison

Electra Therapeutics Synthekine
Founded
2018 2018
Headquarters
Not tracked yet Menlo Park, United States
Employees
25 62 larger
Industry
Biotechnology, Health Care Biotechnology, Health and Wellness, Life Sciences
Funding Stage
Series B Series C
Total Funding
$100.00M $289.50M
Funding Rounds
2 3
Services
Not tracked yet Research and Development of Cytokine Therapeutics, Cytokine Partial Agonists, Surrogate Cytokine Agonists
Target Customers
Not tracked yet Cancer Patients, Patients with Autoimmune Diseases, Healthcare Providers, Pharmaceutical Partners
Taxonomy
Clinical StageTherapeuticsSIRP Targeting TherapiesImmunological DiseasesCancer TreatmentELA026 +8 Cytokine TherapeuticsImmunotherapyCancer TreatmentAutoimmune DisordersProtein EngineeringCytokine Partial Agonism +8
Website
electra-therapeutics.com synthekine.com
Electra Therapeutics logo

About Electra Therapeutics

Electra Therapeutics is a clinical stage biotechnology company founded in 2018. They specialize in developing therapies that target signal regulatory proteins (SIRP) for the treatment of immunological diseases and cancer. Their recent milestone includes an impressive $84.00M Series B investment on 1...

Synthekine logo

About Synthekine

Synthekine, founded in 2018, is a biotechnology company headquartered in the United States, focused on engineered cytokine therapeutics for cancer and autoimmune disorders. By leveraging immunological insights and targeted protein engineering, Synthekine aims to discover and develop groundbreaking t...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Electra Therapeutics and Synthekine for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Electra Therapeutics or Synthekine moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

Electra Therapeutics was founded in 2018, with 25 employees. Electra Therapeutics is a clinical stage biotechnology company founded in 2018. They specialize in developing therapies that target signal regulatory proteins (SIRP) for the treatment of immunological. Synthekine was founded in 2018, based in Menlo Park, United States, with 62 employees. Synthekine, founded in 2018, is a biotechnology company headquartered in the United States, focused on engineered cytokine therapeutics for cancer and autoimmune disorders. By leveraging immunological.
Electra Therapeutics has raised $100.00M and Synthekine $289.50M. Latest stage: Electra Therapeutics Series B, Synthekine Series C.
Both work in Biotechnology and list cancer treatment among their focus areas.

Compare Electra Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Electra Therapeutics on 12 Sep 2024, and Synthekine on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes